Showing 38,541 - 38,560 results of 104,056 for search '(( e point decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.66s Refine Results
  1. 38541
  2. 38542

    MALDI IMS as a tool to dissect the spatial proteome of bacterial biofilms. by Kyle A. Floyd (694632)

    Published 2015
    “…<p>(A) Schematic depicting the culture method for single species surface-associated biofilms. …”
  3. 38543

    BLOCK RESECTION OF LUMBAR OSTEOBLASTOMA. PRESENTATION OF A CASE AND BIBLIOGRAPHICAL UPDATE by Pedro Luis Bazán (6047783)

    Published 2018
    “…<div><p>ABSTRACT Objective: To present the clinical case and update the bibliography. Methods: A male patient, 24 years of age, sought treatment for right lumbosciatalgia of 3 years of evolution with topography L5 and motor deficit (M4). …”
  4. 38544
  5. 38545
  6. 38546
  7. 38547
  8. 38548

    Evaluation and prediction of fish aesthetic values. by Juliette Langlois (12822131)

    Published 2022
    “…(b) Left: The r<sup>2</sup> of the linear relationship between the predicted values averaged across the 5 validation sets and the evaluated values is 0.79 ± SD 0.04 (the color of points indicates the 5 sets used to perform the cross validation). …”
  9. 38549
  10. 38550
  11. 38551
  12. 38552
  13. 38553
  14. 38554
  15. 38555
  16. 38556
  17. 38557
  18. 38558

    <i>C</i><sub>S</sub>‑Symmetric Pyridine(diimine) Iron Methyl Complexes for Catalytic [2+2] Cycloaddition and Hydrovinylation: Metallacycle Geometry Determines Selectivity by Coralie Duchemin (6974873)

    Published 2023
    “…A series of <i>C</i><sub>S</sub>-symmetric (aryl,alkyl)-substituted pyridine(dimine) iron methyl (<sup>Cy</sup>A<sup>R</sup>PDI)FeCH<sub>3</sub> complexes have been prepared, characterized, and evaluated as precatalysts for the [2+2]-cycloaddition of butadiene and ethylene. …”
  19. 38559
  20. 38560

    Results from secondary outcomes of questionnaires. by Isabella Hotz (18831177)

    Published 2024
    “…<p>The before-after graphs represent individual patient’s scorings at baseline (blue squares) and post-intervention (lilac or pink squares) on the (<b>A</b>) FFS, (<b>B</b>) BDI-II, (<b>C</b>) FES-I, (<b>D</b>) EQ-5D-5L VAS and (<b>E</b>) EQ-5D-5L Index. …”